Casi pharmaceuticals announces full year 2020 financial results

Rockville, md. and beijing, march 30, 2021 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a u.s. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the year ended december 31, 2020 and provided an update on key highlights for 2021.

CASI Ratings Summary

CASI Quant Ranking